Elekta has received the CE mark for its Leksell Gamma Knife Icon precision radiosurgery platform, designed to treat virtually any target in the brain, regardless of type, location, or volume. The approval makes Elekta’s latest generation of the Gamma Knife system available in the European market. The company also announced that it has submitted the system for FDA clearance.
The University Hospital La Timone, based in Marseilles, France, has installed the first Icon and will use the system to treat the first patients in July. The facility was also the first hospital in the world to treat patients with the Icon’s predecessor, the Leksell Gamma Knife Perfexion. In the past 23 years, the facility has employed four different versions of Leksell Gamma Knife.
The Icon system offers stereotactic imaging, online Adaptive DoseControl, ultra-precise dose delivery, and the availability of frameless treatments. This last option provides physicians with better technical control, enabling multiple treatment sessions and treatment of lesions in additional anatomical sites. It also allows them to evaluate patient movements and adapt dose proactively in response, according to the facility.
“Leksell Gamma Knife Icon is a new concept for performing precision radiosurgery for all types of cranial cases with unlimited clinical and workflow flexibility,” said Tomas Puusepp, president and CEO of Elekta. “Clinicians can choose either frame-based or frameless methods to immobilize the patient’s head, as well as the option to perform the treatment in a single session or in multiple sessions. Icon is also based on the only technology available that can perform ultra-precise Microradiosurgery for the cases where this is required.”
For more information, visit Elekta.
